High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment

By Kvinnsland S.   Anker G.   Dirix L.-Y.   Bonneterre J.   Prove A.-M.   Wilking N.   Lobelle J.-P.   Mariani O.   di Salle E.   Polli A.   Massimini G.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 976-982

Elsevier

Access to resources Recommend Favorite

Exemestane: A Review of its Use as Adjuvant Treatment for Early Breast Cancer in Postmenopausal Women

By Moen Marit D.   Wagstaff Antona J.  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

Synergistic effects of combined treatment with simvastatin and exemestane on MCF7 human breast cancer cells

By        

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 456-462

Spandidos Publications

Access to resources Recommend Favorite

The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

By Beaver Julia A   Park Ben H  

Future Oncology, Vol. 8, Iss. 6, 2012-06 ,pp. : 651-657

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

By Lundkvist Jonas   Wilking Nils   Holmberg Stig   Jönsson Linus  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 289-299

Springer Publishing Company

Access to resources Recommend Favorite